Combiphar

Combiphar, established in 1971, is a prominent Indonesian company operating within the Pharmaceuticals and Healthcare sectors. The company focuses on developing and manufacturing a range of healthcare products, including consumer and consumer healthcare items. Its commitment to quality and innovation is underscored by its dedicated R&D facility, which concentrates on optimizing prescription drugs to meet stringent Bio-Availability, BioEquivalence, and Nanotechnology standards. This focus ensures the efficacy and advanced nature of their pharmaceutical offerings.

The company's production facility in Padalarang, West Java, is equipped with modern technologies and standard operating procedures. This facility has achieved international certifications such as ISO 14001:2004 for environmental management, demonstrating a commitment to sustainable operations. Furthermore, the Therapeutic Goods Administration (TGA) certification allows certain Combiphar products to be exported to Australia, highlighting its global market access and adherence to international regulatory requirements. The company employs between 1,000 and 5,000 individuals, contributing to its operational scale and capacity. Meet Combiphar's team to understand the expertise driving these operations.

Combiphar has garnered significant recognition for its brand strength and market presence. In 2015, it won the Super Brand award in the "Consumer Healthcare Products and Service" category for OBH Combi & Insto. It also secured top positions as one of "Indonesia's Most Reputable Healthcare Brands 2015," based on brand equity and customer loyalty. With a revenue of $686.5M, Combiphar stands as a major player in the national pharmaceutical landscape, consistently demonstrating its market leadership and consumer trust through its product portfolio and operational excellence.